title: Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.
abstract: BACKGROUND
  Asthma is a heterogeneous disease and development of novel therapeutics requires an understanding of pathophysiologic phenotypes. The purpose of the ADEPT study was to correlate clinical features and biomarkers with molecular characteristics, by profiling asthma (NCT01274507). This report presents for the first time the study design, and characteristics of the recruited subjects.
  
  
  METHODS
  Patients with a range of asthma severity and healthy non-atopic controls were enrolled. The asthmatic subjects were followed for 12 months. Assessments included history, patient questionnaires, spirometry, airway hyper-responsiveness to methacholine, fractional exhaled nitric oxide (FENO), and biomarkers measured in induced sputum, blood, and bronchoscopy samples. All subjects underwent sputum induction and 30 subjects/cohort had bronchoscopy.
  
  
  RESULTS
  Mild (n = 52), moderate (n = 55), severe (n = 51) asthma cohorts and 30 healthy controls were enrolled from North America and Western Europe. Airflow obstruction, bronchodilator response and airways hyperresponsiveness increased with asthma severity, and severe asthma subjects had reduced forced vital capacity. Asthma control questionnaire-7 (ACQ7) scores worsened with asthma severity. In the asthmatics, mean values for all clinical and biomarker characteristics were stable over 12 months although individual variability was evident. FENO and blood eosinophils did not differ by asthma severity. Induced sputum eosinophils but not neutrophils were lower in mild compared to the moderate and severe asthma cohorts.
  
  
  CONCLUSIONS
  The ADEPT study successfully enrolled asthmatics across a spectrum of severity and non-atopic controls. Clinical characteristics were related to asthma severity and in general asthma characteristics e.g. lung function, were stable over 12 months. Use of the ADEPT data should prove useful in defining biological phenotypes to facilitate personalized therapeutic approaches.
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA. psilkoff@its.jnj.com.
authors.forename: P E
authors.initials: PE
authors.lastname: Silkoff
authors.affiliation: Arensia Exploratory Medicine, Sos. Viilor 90, Bucharest, 050159, Romania. irina.strambu@arensia-em.com.
authors.forename: I
authors.initials: I
authors.lastname: Strambu
authors.affiliation: Institut Universitaire de Cardiologie et Pneumologie de Québec (IUCPQ), 2725, Chemin Ste-Foy, Québec, G1V 4G5, Canada. Michel.Laviolette@fmed.ulaval.ca.
authors.forename: M
authors.initials: M
authors.lastname: Laviolette
authors.affiliation: Medicines Evaluation Unit, University Hospital of South Manchester Foundation Trust, University of Manchester, Southmoor Road, Manchester, M23 9QZ, UK. DSingh@meu.org.uk.
authors.forename: D
authors.initials: D
authors.lastname: Singh
authors.affiliation: Institute for Heart and Lung Health, The Lung Centre, 7th Floor, Gordon, Canada. mark.fitzgerald@vch.ca.|Leslie Diamond Health Care Centre, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada. mark.fitzgerald@vch.ca.
authors.forename: J M
authors.initials: JM
authors.lastname: FitzGerald
authors.affiliation: Institute for Heart and Lung Health, The Lung Centre, 7th Floor, Gordon, Canada.|Leslie Diamond Health Care Centre, 2775 Laurel Street, Vancouver, BC, V5Z 1M9, Canada.
authors.forename: S
authors.initials: S
authors.lastname: Lam
authors.affiliation: Department of Thoracic Medicine and Surgery, Temple University School of Medicine, 3401 N. Broad St., Philadelphia, PA, 19140, USA. Steven.Kelsen@tuhs.temple.edu.
authors.forename: S
authors.initials: S
authors.lastname: Kelsen
authors.affiliation: IKF Pneumologie Frankfurt, Institut für klinische Forschung Pneumologie, Clinical Research Centre Respiratory Diseases, Schaumainkai 101-103, Stresemannallee, 360596, Frankfurt, Germany. eich@ikf-pneumologie.de.
authors.forename: A
authors.initials: A
authors.lastname: Eich
authors.affiliation: KLB Gesundheitsforschung Lübeck GmbH, Sandstr. 18, 23552, Lübeck, Germany. A.Ludwig@klb-healthresearch.com.
authors.forename: A
authors.initials: A
authors.lastname: Ludwig-Sengpiel
authors.affiliation: Yale Center for Asthma and Airway Disease, Division of Pulmonary and Critical Care and Sleep Medicine, Yale School of Medicine, TAC 441, 300 Cedar Street, New Haven, CT, 06520, USA. geoffrey.chupp@yale.edu.
authors.forename: G C
authors.initials: GC
authors.lastname: Hupp
authors.affiliation: Department of Respiratory Medicine, Respiratory Research Unit, Bispebjerg University Hospital, Bispebjerg bakke 23, DK-2400, Copenhagen, NV, Denmark. backer@dadlnet.dk.
authors.forename: V
authors.initials: V
authors.lastname: Backer
authors.affiliation: Department of Respiratory Medicine, Respiratory Research Unit, Bispebjerg University Hospital, Bispebjerg bakke 23, DK-2400, Copenhagen, NV, Denmark. posrbjerg@dadlnet.dk.
authors.forename: C
authors.initials: C
authors.lastname: Porsbjerg
authors.affiliation: Univ. Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, F-33000, Bordeaux, France.
authors.forename: P O
authors.initials: PO
authors.lastname: Girodet
authors.affiliation: Univ. Bordeaux, Centre de Recherche Cardio-Thoracique de Bordeaux, INSERM U1045, CIC 1401, F-33000, Bordeaux, France. patrick.berger@u-bordeaux.fr.
authors.forename: P
authors.initials: P
authors.lastname: Berger
authors.affiliation: Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Calgary, AB, T2N 4Z6, Canada. rleigh@ucalgary.ca.
authors.forename: R
authors.initials: R
authors.lastname: Leigh
authors.affiliation: Division of Pulmonary, C ritical Care, and Occupational Medicine, University of Iowa, W219B GH UIHC, 200 Hawkins Drive, Iowa City, IA, 52242, USA. joel-kline@uiowa.edu.
authors.forename: J N
authors.initials: JN
authors.lastname: Kline
authors.affiliation: Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham & Birmingham VA Medical Center, 422 THT, 1900 University Blvd, Birmingham, AL, 35294, USA. mdrans99@uab.edu.
authors.forename: M
authors.initials: M
authors.lastname: Dransfield
authors.affiliation: 4.116 John Sealy Annex, University of Texas Medical Branch, 301 University Blvd, Galveston, TX, 77555-0568, USA. William.Calhoun@utmb.edu.
authors.forename: W
authors.initials: W
authors.lastname: Calhoun
authors.affiliation: Parexel International, Shelton Simmons (MD), 3001 S Hanover St #7, Brooklyn, MD, 21225, USA. Azra.Hussaini@parexel.com.
authors.forename: A
authors.initials: A
authors.lastname: Hussaini
authors.affiliation: Department of Pulmonary and Critical Care, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH, 44195, USA. khatris@ccf.org.
authors.forename: S
authors.initials: S
authors.lastname: Khatri
authors.affiliation: Department of Respiratory Diseases and CIC Nord AP-HM, UMR INSERM U1067 CNRS 7733, Aix-Marseille Université, Marseille, France. Pascal.chanez@univ-amu.fr.
authors.forename: P
authors.initials: P
authors.lastname: Chanez
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: V S
authors.initials: VS
authors.lastname: Susulic
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: E S
authors.initials: ES
authors.lastname: Barnathan
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: M
authors.initials: M
authors.lastname: Curran
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Das
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: C
authors.initials: C
authors.lastname: Brodmerkel
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: F
authors.initials: F
authors.lastname: Baribaud
authors.affiliation: Janssen Research & Development LLC, 1400 McKean Rd, Springhouse, PA, 19477, USA.
authors.forename: M J
authors.initials: MJ
authors.lastname: Loza
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D001249:Asthma / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000378:metabolism / Q000503:physiopathology; D015415:Biomarkers / Q000378:metabolism; D016084:Bronchoconstriction / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002170:Canada / Q000453:epidemiology; D016022:Case-Control Studies; D005060:Europe / Q000453:epidemiology; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D010641:Phenotype; D057285:Precision Medicine; D011237:Predictive Value of Tests; D015995:Prevalence; D012107:Research Design; D012129:Respiratory Function Tests; D012307:Risk Factors; D012720:Severity of Illness Index; D013183:Sputum / Q000378:metabolism; D011795:Surveys and Questionnaires; D013997:Time Factors; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology; D055815:Young Adult
chemical_list: D018927:Anti-Asthmatic Agents; D015415:Biomarkers; D001993:Bronchodilator Agents